There are millions of surgical procedures performed annually worldwide and the market for wound care products and techniques is significant. In the United States alone, there are over 100,000 surgeries performed daily. Surgical and trauma wounds are, by far, the most common types of wounds addressed in the wound care area. Enjoying market success depends on several factors. Manufacturers must develop a formidable strategy, which involves matching internal capabilities with external opportunities. By choosing to implement such strategies, providers are able to achieve high levels of clinical success while controlling use and costs. Manufacturers are continuing to create well-rounded and advanced products to provide a wider variety of choices. The aging of the population and continued advances in biotechnology drive the wound care industry. The aging world population created increased demand for all types of surgical intervention, particularly cardiovascular, orthopedic, urological and dermatological procedures. The emerging generation of wound care products and technologies are well-positioned to capitalize on this growth. Besides the always-improving synthetic dressing materials, newer technologies in wound treatment include the xenogeneic tissue scaffold, bilayered human dermal substitutes, recombinant growth factors, endoscopic subfascial ligation of venous perforators, and endovascular arterial repair techniques. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes.
Wound Care: Surgical and Trauma Wounds details total manufacturers’ revenues from the following product categories:
Wound Closure
Sutures
Staples
Tissue adhesives, sealants and glues
Anti-infectives
Surgical and trauma wound management
Wound cleaners
Debridement
Tapes
Dry dressings
Moist Dressings
Alginates
Films
Foams
Hydrocolloids
Hydrogels
Biological Dressings
Artificial Skin
Collagen
Growth Factors
Miscellaneous Treatments
The information and analysis presented in this report are based on an extensive survey of senior management in the prescription women’s health drug industry. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with industry executives and product managers to validate and obtain expert opinion on current and future trends in the women’s health industry.
Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections. All market data pertains to the U.S. market at the manufacturers’ level. Revenues in the report are based on sales at the manufacturers’ level for the following markets:
Wound Closure
Anti-infectives
Surgical and Trauma Wound Management
Moist Dressings
Biological Dressings
Miscellaneous Surgical Wound and Trauma Treatments
The market is varied in terms of both product offerings and product maturity. Several of the segments are mature such as anti-infectives, wound management, and sutures and staples of the wound closure market, while others such as biological dressings, some moist dressings, and sealants, adhesives, and glues of the wound closure segment are in the infant stages of development.
Thus some segments within the market are slowing in growth rates while others are driving growth. As identified in the report, conventional, mature products continue to generate the majority of sales; however, their growth rate is slow and limited by the maturity of the product and the competition. Advancements in technology are expected to drive growth during the forecast period.
Product Managers, Marketing Directors in the wound care industry as well as financial and consulting executives are among those that will find this a useful resource.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Size and Growth of the Market
Trends Affecting the Market
Competitive Outlook
CHAPTER TWO: INTRODUCTION AND OVERVIEW
Surgical Wounds
Trauma Wounds
Normal Integument
Epidermis
Dermis
Subcutaneous Tissue
Functions of Skin
Effects of Aging on the Integumentary System
Types of Wound Healing
Defense Against Injury
Mononuclear Phagocyte System
Inflammatory Response
Wound Healing Process
Primary Intention
Secondary Intention
Tertiary Intention
Delays of Wound Healing
Complications of Wound Healing
Hypertrophic Scars and Keloid Formation
Contracture
Dehiscence
Excess Granulation Tissue
Adhesions
CHAPTER THREE: SURGICAL DRESSINGS
CHAPTER FOUR: TREATMENTS
Overview
Wound Closure
Overview and Products
Sutures
Absorbable
Surgical Gut
Synthetic Absorbable Polymers
Nonabsorbable
Surgical Silk
Surgical Cotton
Linen
Surgical Stainless Steel
Synthetic Nonabsorbable Polymers
Staplers and Staples
Tissue Adhesives, Sealants and Glues
Fibrin-based
Collagen-based
Vascular Closing Devices
Polymeric Sealants
Synthetic Adhesives/Glues
Market Segment Conclusion
Anti-Infectives
Overview and Products
Market Segment Conclusion
Surgical and Trauma Wound Management
Overview and Products
Cleansing
Debridement
Tapes
Dry Dressings
Market Segment Conclusion
Moist Dressings
Overview and Products
Alginates
Hydrocolloids
Hydrogels
Films
Foams
Market Segment Conclusion
Biological Dressings
Overview and Products
Artificial Skin
Collagen
Growth Factors
Market Segment Conclusion
Miscellaneous Surgical Wound and Trauma Treatments
Overview and Products
Market Segment Conclusion
CHAPTER FIVE: MARKET SIZE AND FORECAST SUMMARY
CHAPTER SIX: COMPETITIVE ANALYSIS
Total Surgical and Trauma Wound Market
Competitive Market Share by Segment
Wound Closure
Anti-Infectives
Surgical and Trauma Wound Management
Moist Dressings
Biological Dressings
Miscellaneous Treatments
CHAPTER SEVEN: INDUSTRY DEVELOPMENTS
Product Categorization
New Products
Reimbursement
Novel Treatments
Miscellaneous Treatments
Honey Treatment
Battle-ready Bandage Treatment
Silverlon
Low Intensity Laser Therapy
In Development
Merrem IV
OrCel
Allox
Thymosin Beta 4
Encelle E Matrix
KGF-2
BioFoam
CoFoam Polyurethne Composite
LyphoDerm
KGF-2
Demegen
HB50
Other Miscellaneous Developments
Psychosocial Factors in Wound Healing
Scar Treatment
Keloid Scars
Hypertrophic Scars
Hormones and Wound Healing
Surgical Infection
Demographics and Epidemiology
CHAPTER EIGHT: COMPANY PROFILES
Abbott Vascular Devices
Baxter BioScience
Bertek Pharmaceuticals, Inc.
Carrington Laboratories, Inc.
ConvaTec, Ltd.
Datascope Corporation
Ethicon, Inc.
GlaxoSmithKline Plc
Healthpoint, Ltd.
Johnson & Johnson
Kinetic Concepts, Inc.
Pfizer, Inc.
Smith & Nephew, plc
St. Jude Medical, Inc.
United States Surgical
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: Worldwide Surgical and Trauma Wound
Product Revenues by Segment 1999-20095CHAPTER FOUR: TREATMENTS
Table 4-1: Selected Absorbable Sutures by Manufacturers and Products32
Table 4-2: Selected Nonabsorbable Sutures by Manufacturers and Products36
Table 4-3: Selected Staplers and Staples Manufacturers and Products40
Table 4-4: Selected Tissue Adhesives, Sealants, and Glues Manufacturers and Products46
Table 4-5: World Market for Wound Closure Products by Type (Sutures; Staplers and Staples; Tissue Adhesives, Sealants, and Glues) 1999-200947
Table 4-7: Selected Topical Brand Name Anti-Infectives49
Table 4-8: The World Market for Anti-Infectives for Surgical and Trauma Wounds 1999-200950
Table 4-9: Toxicity Index for Selected Wound Cleansers52
Table 4-10: Selected Cleansing Agents Currently on the Market53
Table 4-11: Selected Debridement Agents Currently Available55
Table 4-12: Selected Adhesive Strips and Tapes Currently on the Market58
Table 4-13: Selected Dry Dressing (Woven and Nonwoven) Currently on the Market60
Table 4-14: World Market for Wound Management Products for Surgical and Trauma Wounds Revenues by Segment (Cleansing, Debridement, Tapes, Dry Dressings) 1999-200961
Table 4-15: Selected Alginate Products Currently on the Market63
Table 4-16: Selected Hydrocolloid Products Currently on the Market68
Table 4-17: Selected Hydrogel Products Currently on the Market71
Table 4-18: Selected Films Currently on the Market76
Table 4-19: Selected Foam Products Currently on the Market79
Table 4-20: Moist Dressings for Surgical and Trauma Wounds, Revenues by Segment (Alginates, Hydrocolloids, Hydrogels, Films,Foams) 1999-200983
Table 4-21: Selected Artificial Skin Products Currently on the Market87
Table 4-22: Selected Collagen Products Currently on the Market
Table 4-23: World Market for Biological Dressings for Surgical and Trauma Wounds, Revenues by Segment (Artificial Skins, Collagen Products, Other Products) 1999-200993Table 4-24: Selected Miscellaneous Surgical Wound and Trauma Treatment Manufacturers and Products98Table 4-25: World Market for Miscellaneous Surgical and Trauma Wound Treatments 1999-2009: 99CHAPTER FIVE: MARKET SIZE AND FORECAST SUMMARYTable 5-1: World Surgical and Trauma Wound Product Revenues by Segment 1999-2009102Figure 5-1: Surgical and Trauma Wound Care Revenues by Segment 1999-2009103Table 5-2: Surgical and Trauma Wound Care Share by Segment 1999-2009104Figure 5-2: Surgical and Trauma Wound Care Market Share by Segment 2004 vs 2009105CHAPTER SIX: COMPETITIVE ANALYSISTable 6-1: Major Competitors and Segments of Participation 2004109-112Table 6-2: The World Surgical and Trauma Wound Care Market Revenues and Market Share by Leading Supplier 2004113Figure 6-1: Surgical and Trauma Wound Care Market Share by Leading Supplier 2004114Table 6-3: Surgical and Trauma Wound Closure Revenues and Market Share by Leading Supplier 2004115Table 6-4: Anti-Infectives for Surgical and Trauma Wounds Revenues and Market Share by Leading Supplier 2004116Table 6-5: Surgical and Trauma Wound Management Revenues and Market Share by Leading Supplier 2004117Table 6-6: Moist Dressings for Surgical and Trauma Wounds Revenues and Market Share by Leading Supplier 2004118Table 6-7: Biological Dressings for Surgical and Trauma Wounds Revenues and Market Share by Leading Supplier 2004119Table 6-8: Miscellaneous Surgical and Trauma Wound Treatments Revenues and Market Share by Leading Supplier 2004120 CHAPTER SEVEN: INDUSTRY DEVELOPMENTSTable 7-1: Global and U.S. Population by Age Group and Sex 1999, 2004, and 2009145Figure 7-1: U.S. Population by Age Group, 1999, 2004, and 2009146Figure 7-2: Global Population by Age Group, 1999, 2004, and 2009146Table 7-2: Global and U.S. Yearly Incidence of Surgical and Trauma Wounds by Type147
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.
